Provider Skill Building for Hypertension
(REACH - HTN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help doctors improve their communication skills with patients, particularly those with hypertension (high blood pressure). Doctors will participate in a skills training program called REACH - Hypertension, and some patient visits will be recorded to evaluate the training's effectiveness. Patients will not receive new treatments, but their visits will be audio-recorded to assess the program's impact. Individuals with high blood pressure who see a participating doctor at Duke Primary Care might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to enhance doctor-patient communication, potentially improving care for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this skills training program is safe for doctors?
A previous study, the REACH program, aimed to improve communication between doctors and patients to better manage high blood pressure. This study did not involve medications, eliminating concerns about typical drug side effects. Instead, it assessed whether doctors could easily participate in the skills training and find it useful.
The research showed no health risks or negative effects for doctors from the training. As this trial focuses on enhancing communication skills, it does not involve treatments that could cause medical side effects. The main focus is on the practicality and usefulness of the training for doctors.12345Why are researchers excited about this trial?
Researchers are excited about the "Provider Skill Building for Hypertension" trial because it focuses on enhancing doctors' skills, rather than introducing a new medication. Unlike standard hypertension treatments, such as ACE inhibitors or beta-blockers, this approach aims to improve how clinicians manage hypertension and interact with patients. By completing a 5-6 week program, doctors can potentially improve patient outcomes through better communication and personalized care, which could lead to more effective hypertension management across the board.
What evidence suggests that this skills training program is effective for improving doctor-patient communication in hypertension care?
This trial will evaluate the impact of provider skill-building on hypertension management. Research has shown that healthcare providers can manage high blood pressure more effectively with specialized training. In this trial, doctors in the "Clinicians" arm will complete a program designed to enhance their communication and engagement skills over 5-6 weeks. Studies have found that improved communication and engagement with patients lead to better blood pressure control. Early results suggest that when doctors work closely with patients, those patients are more likely to adhere to their treatment plans and monitor their blood pressure at home. Other research has shown that managing high blood pressure remotely can also improve control and encourage home monitoring. This evidence supports the importance of improving communication between doctors and patients for managing high blood pressure.678910
Who Is on the Research Team?
Investigator, PhD
Principal Investigator
Duke University
Investigator, MD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for doctors who manage hypertension. They must be willing to have their patient interactions recorded, participate in a training program, and provide feedback through questionnaires and interviews.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training Program
Doctors complete a skills training program to improve communication with patients
Post-Training Assessment
Doctors' patient appointments are audio-recorded and questionnaires are completed
Follow-up
Participants are monitored for changes in patient-centeredness and blood pressure
What Are the Treatments Tested in This Trial?
Interventions
- REACH - Hypertension
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator